Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$119,672
-$24,437 QoQ
Shares Held
11,518
-14.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#226
of 334 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. PRGO ranks #18 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in PRGO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,672 | 11,518 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $144,109 | 13,418 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $140,842 | 10,118 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $705,246 | 31,668 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $1,118,712 | 41,868 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,173,978 | 41,868 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,076,426 | 41,868 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,098,197 | 41,868 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,075,170 | 41,868 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,347,730 | 41,868 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,415,276 | 43,980 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,405,161 | 43,980 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,493,121 | 43,980 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,577,562 | 43,980 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,499,278 | 43,980 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,129,708 | 31,680 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,285,257 | 31,680 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,217,462 | 31,680 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,232,352 | 31,680 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $965,532 | 20,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,165,736 | 25,425 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,052,624 | 26,010 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,671,329 | 149,180 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,982,601 | 173,875 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||